This is still only the beginning. “Moderna has given out the first doses of an mRNA-based influenza vaccine to participants in an early-phase clinical trial, the company announced Wednesday.” | learn more
The Economist fast forwards 10 years into the future. The story “is fiction, but grounded in historical fact, current speculation and real science.” | learn more
“Extending the human lifespan beyond 100 years.” Sinclair is a geneticist and world-leading expert on longevity. | learn more
“Fitness trackers are often mainly used to count steps but your heart-rate metrics can also be revealing, doctors say” | learn more
On the heels of last week’s Peter Attia link, here’s his fleshed out article full of citations. “Some experts suggest CGMs are useless for nondiabetics. I disagree.” For those new to Peter Attia, he’s a practicing physician (MD) focusing on the […]
“Additionally, Peter explains why he encourages all his patients, even nondiabetics, to utilize a continuous glucose monitor (CGM) which gives important insights that traditional lab testing and metrics consistently miss.” Related: NutriSense! | learn more
Coming soon: “At FOXO Technologies, we are committed to developing a new underwriting protocol based on the science of epigenetics.” | learn more
The approval came despite the advisory committee’s near-unanimous vote against it. “The approval, however, will do little to quell criticisms from the swath of Alzheimer’s researchers, biostatisticians, and clinicians who have argued that Biogen cherry-picked data and failed to show […]
This article in Wired (a couple years old) highlights companies that commercialize epigenetic clocks that predict biological age. I first learned of this technology in the book Lifespan, but I haven’t paid to take my own test yet. Have you? | learn more
“The two will tap hospital chain HCA’s private patient records to train machine learning models, which could help monitor patients, improve operations, and guide doctors’ decision-making.” | learn more